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Abstract. 
 
Adducin is a heteromeric protein with sub-
units containing a COOH-terminal myristoylated ala-
nine-rich C kinase substrate (MARCKS)-related do-
main that caps and preferentially recruits spectrin to 
the fast-growing ends of actin filaments. The basic 
 
MARCKS-related domain, present in 
 
a
 
, 
 
b
 
, and 
 
g
 
 addu-
cin subunits, binds calmodulin and contains the major 
phosphorylation site for protein kinase C (PKC). This 
report presents the first evidence that phosphorylation 
 
of the MARCKS-related domain modifies in vitro
 
 
 
and 
in vivo activities of adducin involving actin and spec-
trin, and we demonstrate that adducin is a prominent in 
vivo substrate for PKC or other phorbol 12-myristate 
13-acetate (PMA)-activated kinases in multiple cell 
types, including neurons. PKC phosphorylation of na-
tive and recombinant adducin inhibited actin capping 
measured using pyrene-actin polymerization and abol-
ished activity of adducin in recruiting spectrin to ends 
and sides of actin filaments. A polyclonal antibody spe-
cific to the phosphorylated state of the RTPS-serine, 
which is the major PKC phosphorylation site in the 
MARCKS-related domain, was used to evaluate phos-
phorylation of adducin in cells. Reactivity with phos-
phoadducin antibody in immunoblots increased two-
fold in rat hippocampal slices, eight- to ninefold in 
human embryonal kidney (HEK 293) cells, threefold in 
MDCK cells, and greater than 10-fold in human eryth-
rocytes after treatments with PMA, but not with for-
skolin. Thus, the RTPS-serine of adducin is an in vivo 
phosphorylation site for PKC or other PMA-activated 
kinases but not for cAMP-dependent protein kinase in 
a variety of cell types. Physiological consequences of 
the two PKC phosphorylation sites in the MARCKS-
related domain were investigated by stably transfecting 
MDCK cells with either wild-type or PKC-unphosphor-
ylatable S716A/S726A mutant 
 
a
 
 adducin. The mutant 
 
a
 
 
adducin was no longer concentrated at the cell mem-
brane at sites of cell–cell contact, and instead it was dis-
tributed as a cytoplasmic punctate pattern. Moreover, 
the cells expressing the mutant 
 
a
 
 adducin exhibited in-
creased levels of cytoplasmic spectrin, which was colocal-
ized with the mutant 
 
a
 
 adducin in a punctate pattern. Im-
munofluorescence with the phosphoadducin-specific 
antibody revealed the RTPS-serine phosphorylation of 
adducin in postsynaptic areas in the developing rat hip-
pocampus. High levels of the phosphoadducin were 
detected in the dendritic spines of cultured hippocampal 
neurons. Spectrin also was a component of dendritic 
spines, although at distinct sites from the ones containing 
phosphoadducin. These data demonstrate that adducin 
is a significant in vivo substrate for PKC or other PMA-
activated kinases in a variety of cells, and that phosphor-
ylation of adducin occurs in dendritic spines that are 
believed to respond to external signals by changes in mor-
phology and reorganization of cytoskeletal structures.
Key words: membrane skeleton • cytoskeleton • actin 
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A
 
dducin
 
 is a ubiquitously expressed calmodulin-bind-
ing protein (Gardner and Bennett, 1986; Bennett
et al., 1988) and substrate for protein kinase C
(PKC)
 
1
 
 (Palfrey and Waseem, 1985; Cohen and Foley,
1986; Ling et al., 1986; Kaiser et al., 1989). Adducin was
first purified from human erythrocyte membrane skeletons
(Gardner and Bennett, 1986) and from brain membranes
(Bennett et al., 1988). Adducin is localized at spectrin–actin
junctions in erythrocyte membrane skeletons (Derick et
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1. 
 
Abbreviations used in this paper
 
: AMPA, 
 
a
 
-amino-3-hydroxy-5-methyl-
4-isoxazole proprionic acid; CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione;
 
HA, hemagglutinin; IBMX, 3-isobutyl-1-methylxanthine; MARCKS,
myristoylated alanine-rich C kinase substrate; NMDA, 
 
N
 
-methyl-
 
d
 
-aspar-
tate; PKA, cAMP-dependent protein kinase; PKC, protein kinase C; PKM;
the catalytic domain of protein kinase C; PMA, phorbol 12-myristate
13-acetate.
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al. 1992) and colocalizes with spectrin at sites of cell–cell
contact in epithelial cells (Kaiser et al., 1989; Hu et al.,
1995) and in dendritic spines of hippocampal neurons
(Seidel et al., 1995). Adducin exhibits in vitro
 
 
 
activities of
promoting association of spectrin with actin (Gardner and
Bennett, 1987; Bennett et al., 1988), association with sides
of actin filaments (Mische et al., 1987; Taylor and Taylor,
1994), and capping the fast-growing ends of actin filaments
(Kuhlman et al., 1996). Recently, adducin has been dem-
onstrated to preferentially cap and recruit spectrin to the
fast-growing ends of actin filaments (Li et al., 1998).
Adducin is a heteromeric protein comprised of either 
 
a
 
and 
 
b 
 
or 
 
a 
 
and 
 
g 
 
subunits (Gardner and Bennett, 1986;
Bennett et al., 1988; Dong et al., 1995; Hughes and Ben-
nett, 1995). 
 
a 
 
adducin is expressed in most tissues, while 
 
b
 
adducin has a more restricted pattern of expression (Joshi
et al., 1991). 
 
g 
 
adducin, which is similar in sequence to 
 
a
 
and 
 
b 
 
adducin, is a likely companion for 
 
a 
 
adducin in cells
lacking the 
 
b 
 
subunit (Dong et al., 1995). Adducin sub-
units are closely related in amino acid sequence and do-
main organization (Joshi and Bennett, 1990; Joshi et al.,
1991; Dong et al., 1995). Each adducin subunit has three
distinct domains: a 39-kD NH
 
2
 
-terminal globular protease-
resistant head domain, connected by a 9-kD “neck” do-
main to a COOH-terminal protease-sensitive tail domain
(Joshi and Bennett, 1990; Joshi et al., 1991; Dong et al.,
1995). Adducin isolated from erythrocytes is a mixture of
heterodimers and tetramers with NH
 
3
 
-terminal head do-
mains in contact to form a globular core and with interact-
ing tails extended away from the core (Hughes and Ben-
nett, 1995).
COOH termini of all three subunits of adducin contain a
highly basic stretch of 22 amino acids with sequence simi-
larity to a domain in the myristoylated alanine-rich C ki-
nase substrate (MARCKS protein) (Joshi et al., 1991;
Dong et al., 1995). The MARCKS-related domain is re-
quired for interactions of adducin with actin and spectrin,
which is consistent with the possibility that the MARCKS-
related domain mediates contact with actin (Li et al.,
1998). The MARCKS-related domain also has a major
phosphorylation site, the RTPS-serine, for PKC as well as
cAMP-dependent protein kinase (PKA), and contains the
primary calmodulin-binding site of adducin (Matsuoka
et al., 1996). Ca
 
2
 
1
 
/calmodulin inhibits actin-capping and
spectrin recruitment activities of adducin (Gardner and
Bennett, 1987; Kuhlman et al., 1996). Although phosphor-
ylation of the MARCKS-related domain by PKC inhibits
calmodulin binding (Matsuoka et al., 1996), effects of
phosphorylation on the other activities of adducin have
not been resolved.
The MARCKS family of proteins has been studied ex-
tensively as in vivo substrates of PKC (Aderem, 1992;
Blackshear, 1993). A 25–amino acid basic domain is the
site for both PKC phosphorylation and calmodulin bind-
ing of the MARCKS protein and is similar in sequence to
the MARCKS-related domain of adducin (Aderem, 1992;
Blackshear, 1993). The MARCKS protein binds and cross-
links actin in in vitro assays, and its capacity to cross-link
actin is regulated by PKC phosphorylation and calmodu-
lin-binding to the phosphorylation site domain (Hartwig
et al., 1992). A COOH-terminal (C1) region in the NR1
subunit of 
 
N-
 
methyl-
 
d
 
-aspartate (NMDA) receptor, a
 
glutamate receptor of neuron, has sequence similarity to
the PKC phosphorylation/calmodulin-binding domain of
the MARCKS protein (Tingley et al., 1993; Ehlers et al.,
1996). The C1 region also contains PKC phosphorylation
sites and is a high-affinity binding site for calmodulin (Tin-
gley et al., 1993; Ehlers et al., 1996). Moreover, phosphory-
lation and calmodulin-binding to the C1 region may regu-
late interaction of the NR1 subunit of NMDA receptor
with the actin cytoskeleton (Ehlers et al., 1995, 1996). The
PKC phosphorylation site domain of the MARCKS pro-
tein is also involved in its cell membrane binding through
the interaction between a cluster of basic residues and
acidic phospholipids, such as phosphatidylserine (Kim et al.,
1994; McLaughlin and Aderem, 1995). Phosphorylation of
the serine residues in the poly-basic domain reduces its
electrostatic interaction with the phospholipids and has
been proposed to provide an electrostatic switch mecha-
nism for the reversible binding of the MARCKS protein to
the cell membrane.
This report presents evidence that adducin is an in vivo
substrate for PKC or other phorbol 12-myristate 13-ace-
tate (PMA)-activated kinases, and that activities of addu-
cin in capping and recruiting spectrin to actin filaments are
regulated by PKC phosphorylation of the MARCKS-
related domain. Mutation of the two PKC phosphoryla-
tion sites in the MARCKS-related domain of 
 
a 
 
adducin
produced striking effects on distribution of the mutant ad-
ducin as well as of spectrin in MDCK cells. Adducin phos-
phorylated at the major PKC site in the MARCKS-related
domain was specifically localized in dendritic spines of cul-
tured neurons. Adducin is a candidate molecule to medi-
ate downstream consequences of PKC activation in post-
synaptic sites in neurons as well as other dynamic cellular
domains. 
 
Materials and Methods
 
Proteins 
 
Actin was purified from acetone powder of rabbit skeletal muscle (Pardee
and Spudich, 1982) with a modification (Li and Bennett, 1996). Brain
spectrin was isolated by high salt extraction from bovine brain membranes
(Davis and Bennett, 1983; Li and Bennett, 1996). Erythrocyte adducin and
a recombinant 
 
b
 
 adducin (
 
b
 
335–726
 
) were purified as previously described
(Hughes and Bennett, 1995; Li et al., 1998). The catalytic domain of PKC
was purchased from Calbiochem (San Diego, CA).
 
Antibodies 
 
Phosphoadducin-specific rabbit polyclonal antibody was raised against a
synthetic phosphopeptide (FRTPphosphoSFLKK) (Andrews et al., 1991)
corresponding to the major PKC phosphorylation site of adducin (Mat-
suoka et al., 1996) and affinity-purified as described (Matsuoka et al., 1992).
This antibody was preincubated with the unphosphorylated form of the
peptide and used in this study. Polyclonal antibodies against 
 
a
 
 adducin and
the MARCKS-related domain were generated using a recombinant human
 
a
 
 adducin (residues 536–737) and a synthetic peptide corresponding to the
residues 696–726 of human 
 
b
 
 adducin, respectively, as antigens. Affinity-
purified rabbit polyclonal antibody against brain spectrin was reported previ-
ously (Davis and Bennett, 1983). An anti–spectrin 
 
b
 
G
 
 monoclonal antibody
was raised against a synthetic peptide corresponding to the residues 2096–
2122 of human 
 
b 
 
spectrin. Monoclonal anti-hemagglutinin (HA) epitope an-
tibody (HA.11) was purchased from Berkeley Antibody Co. (Richmond,
CA), monoclonal antisynaptophysin antibody was from Boehringer Mann-
heim (Indianapolis, IN), anti-GluR2/4 antibody (clone 3A11) was from
PharMingen (San Diego, CA), and FITC- and TRITC-conjugated goat
secondary antibodies were from Pierce Chemical Co. (Rockford, IL). 
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Phosphorylation of Adducin and Protease Digestion
 
Erythrocyte adducin (2.5 
 
m
 
M monomer) and 
 
b
 
335–726
 
 (5 
 
m
 
M monomer)
were phosphorylated by incubation with 0.4 
 
m
 
g/ml catalytic domain of
PKC (PKM), 0.1 mM ATP, 5 mM MgCl
 
2
 
, 2 mM sodium EGTA, 25 mM
Tris-HCl, pH 7.5 at 15
 
8
 
C for 12–14 h. The reaction was terminated by add-
ing 50 nM (final) bisindolylmaleimide (Calbiochem). ATP was added to
the unphosphorylated adducin sample after quenching the reaction. To
measure stoichiometry of the phosphorylation, adducin was phosphory-
lated in parallel using 0.1 mM [
 
g
 
-
 
32
 
P]ATP. The sample was processed as
described previously (Matsuoka et al., 1996). In some experiments,
[
 
32
 
P]phosphoadducin (50 
 
m
 
g) was digested with 
 
Staphylococcus aureus
 
 V8
protease (1:50 wt/wt; Pierce Chemical Co.) for 3 h at 30
 
8
 
C as described
previously (Matsuoka et al., 1996). After quenching the digestion by add-
ing 2 mM PMSF, the sample was applied to an S-Sepharose column (0.5
ml bed volume; Pharmacia Biotech, Piscataway, NJ) equilibrated with 20
mM Tris-HCl, 2 mM sodium EGTA, 1 mM DTT, 1 mM PMSF, pH 8.0
(column buffer). Fractions (0.2 ml) were collected by eluting the column
with a step gradient of NaBr (0.1, 0.2, 0.3, and 0.5 M in the column buffer)
after wash with the column buffer and subjected to scintillation counting
and SDS-PAGE (3.5–17%).
 
Actin Polymerization and Depolymerization Assays 
 
Pyrene-labeled actin was prepared according to the method modified by
Weber et al. (1987). G buffer (5 mM Tris-HCl, 0.2 mM Na
 
2
 
ATP, 0.5 mM
2-mercaptoethanol, 0.2 mM CaCl
 
2
 
, 0.005% sodium azide, pH 8.0, at 25
 
8
 
C)
was used in all assays. The assay used to quantitate inhibition of actin po-
lymerization at the barbed ends used the method of Pollard (1983), in
which rapid polymerization was initiated using F-actin nuclei. 
 
Spectrin Recruitment Assay 
 
A full description of this assay system is presented in Li et al. (1998).
 
Immunoblotting 
 
Hippocampal slices (220 
 
m
 
m) were prepared from 5–6-wk-old Sprague-
Dawley rats according to Garver et al. (1995). Slices were immediately im-
mersed in an ice-cold preincubation buffer (Garver et al., 1995) and incu-
bated with 40 
 
m
 
M 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris
Cookson, Ballwin, MO) in the buffer at 37
 
8
 
C for 30 min. Buffer was re-
placed with the fresh one without CNQX before further manipulations.
Human erythrocytes were separated and resuspended in the modified
Hepes-Tyrode buffer (Matsuoka et al., 1994) at a final concentration of
20%. Human embryonal kidney cell line (HEK 293; American Type Cul-
ture Collection, Rockville, MD) was maintained in 5% FCS/DME and se-
rum-starved overnight before the following treatments. Human erythro-
cytes (1 ml suspension), HEK 293 cells (
 
f
 
 6-cm dish), and rat hippocampal
slices (5–10 slices) were treated either with 50 
 
m
 
M 3-isobutyl-1-methylxan-
thine (IBMX; Calbiochem)/50 
 
m
 
M forskolin (Calbiochem) or 1 
 
m
 
M PMA
(Calbiochem) at 37
 
8
 
C for 15 min. After the treatments, erythrocytes were
lysed, and the membrane fractions were collected. Erythrocyte mem-
branes, HEK 293 cells, and rat hippocampal slices were solubilized in a
minimum volume of 50 mM Tris-HCl, pH 7.5, 7 M urea, 1% SDS, 5 mM
sodium EDTA, 1 mM DTT, 10 
 
m
 
g/ml leupeptin, 1 mM PMSF with brief
sonication. Proteins (10 
 
m
 
g) were separated by SDS gel electrophoresis
with buffers of Fairbanks et al. (1971) on 5% gels in 0.2% SDS. The
amounts of phosphoadducin and 
 
a
 
 adducin were determined from scans
of the autoradiographs using a densitometer as described elsewhere (Mat-
suoka et al., 1994). The amount of phosphoadducin in each lane was nor-
malized by the amount of 
 
a
 
 adducin loaded and was used to calculate the
change of phosphoadducin level after treatment.
 
Construct Generation and Transfection of MDCK Cells 
 
An HA epitope–tagged wild-type 
 
a
 
 adducin cDNA in pGEMEX vector
was used as a template to mutate the PKC phosphorylation sites in
MARCKS-related domain (Ser716 and Ser726) to alanine residues. Sense
(5
 
9
 
-CCGGCCTTTCTTAAGAAGAGCAAGAAGAAGAGTGACTCC-
3
 
9
 
) and antisense (5
 
9
 
-GGTACGAAACTTCTTCTTCTTTTTGGCTGG-
GGACTTGC-3
 
9
 
) primers were used to mutate the sites with the Exsite
PCR-based mutagenesis kit (Stratagene, La Jolla, CA). Mutation of the
construct was confirmed by DNA sequencing. Both HA epitope–tagged
wild-type and PKC sites–mutated 
 
a
 
-adducin cDNA were subcloned into
pCMV vector (Garver et al., 1997) at NheI-XhoI sites. Transfection of
 
MDCK cells was performed using lipofectamine (GIBCO-BRL, Gaithers-
burg, MD) as described elsewhere (Garver et al., 1997).
 
Rat Hippocampal Cell Culture 
 
Isolation of hippocampal formations from newborn (P2) Sprague-Dawley
rats and the dissociation of neurons was performed as described (Brewer
et al., 1993) with a modification. Briefly, hippocampi from newborn rats
were first incubated with 0.027% trypsin in HBSS without Ca
 
2
 
1
 
 and Mg
 
2
 
1
 
,
0.035% sodium bicarbonate, 1 mM pyruvate, 10 mM Hepes, pH 7.4
(HBSS), in a 95% O
 
2
 
, 5% CO
 
2
 
 incubator for 20 min at 35
 
8
 
C. Hippocampi
were washed with HBSS and triturated through a 1-ml plastic pipette tip
in HBSS. 1 ml of cell suspension was diluted with 2 ml HBSS with Ca
 
2
 
1
 
,
Mg
 
2
 
1
 
. The cells were collected by centrifugation for 1 min at 200 
 
g
 
, resus-
pended in Neurobasal medium (GIBCO-BRL) containing 0.5 mM
glutamine, 25 
 
m
 
M glutamate, and 1% B-27 supplement (GIBCO-BRL),
and plated at a concentration of 160 cells/mm
 
2
 
. Half of the culture me-
dium was replaced by the same medium without glutamate every 4 d. Pri-
mary culture of hippocampal neuron was maintained for at least 7 d be-
fore the following treatment. Neurons were incubated with fresh
Neurobasal medium (no glutamate) containing 15 mM MgCl
 
2
 
 without
B-27 supplement for 90 min, and with 40 
 
m
 
M CNQX for a further 30 min
before activation. The medium was changed to the new one (0.8 mM
MgCl
 
2
 
), and either 10 
 
m
 
M glutamate or 1 
 
m
 
M PMA was applied to the
neurons at 37
 
8
 
C for 6 min.
 
Immunofluorescence 
 
P15 rat brain was fixed and processed as described elsewhere (Lambert
and Bennett, 1993). Cells were fixed with 4% formaldehyde (freshly made
from paraformaldehyde) in 0.1 M phosphate buffer, pH 7.4, containing
0.32 M sucrose for 10 min at room temperature. After fixation, cells were
permeabilized and blocked with 0.05% Triton X-100 (1% for MDCK cells)
in a blocking buffer (PBS with 10% goat serum, 1% BSA, and 5% sucrose)
for 15 min at room temperature. Cells were then incubated with primary an-
tibodies diluted in the blocking buffer followed by FITC- or TRITC-conju-
gated goat secondary antibodies (1.5 
 
m
 
g/ml; Pierce Chemical Co.).
 
Results
 
PKC Phosphorylation of the MARCKS-related Domain 
of Adducin Modulates Activities of Actin Capping and 
Promoting Spectrin–Actin Complexes
 
In a previous study, we did not observe an effect of PKC
phosphorylation on the activity of adducin in promoting
binding of spectrin to F-actin (Matsuoka et al., 1996). In
these experiments, phosphatidylserine and a phorbol ester
were included to activate PKC isolated from rat brain,
which was used at a concentration of 125 nM (Matsuoka
et al., 1996). It is possible that either PKC itself, a contam-
inant in the PKC preparation, or phosphatidylserine ob-
scured effect of the phosphorylation in the assay, even
though in some experiments the phosphoadducin was iso-
lated by cation exchange chromatography. In the present
study, PKM, which lacks the regulatory domain and does
not require phosphatidylserine or PMA for its activity, was
used at 15-fold lower concentrations than used previously to
phosphorylate adducin. Kinase activity was quenched with
bisindolylmaleimide, and adducin samples in the phosphor-
ylation mixture were directly used for actin capping and
spectrin recruitment assays in this study. Controls included
the kinase and inhibitor, with ATP added after quenching
the phosphorylation reaction.
The MARCKS-related domain of adducin was also the
major phosphorylation site for PKM. 75% of the radioac-
tivity in V8 protease digests of 
 
32
 
P-labeled adducin phos-
phorylated by PKM (0.9 mol phosphate/mol subunit) asso- 
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ciated with fragments migrating at the same position as the
MARCKS-related domain of 
 
b
 
 adducin (Fig. 1 
 
A
 
). In ad-
dition, these fragments were highly positively charged,
since the polypeptides tightly bound to a cation-exchange
resin at pH 8 (
 
.
 
0.3 M NaBr was required to elute the frag-
ments) (Fig. 1 
 
A
 
), as did the polybasic MARCKS-related
domain (Matsuoka et al., 1996). Therefore, the V8 frag-
ments most likely are the MARCKS-related domains of 
 
a
 
and 
 
b
 
 adducin. PKM also phosphorylated the major PKC-
site in the MARCKS-related domain based on immunore-
activity with phosphoadducin-specific antibody (see be-
low) (Fig. 3 
 
C
 
). Similar results were obtained using the
neck–tail domain construct of human 
 
b
 
 adducin (
 
b
 
335–726
 
)
(data not shown). Taken together, these results support
the conclusion that the MARCKS-related domain is the
major phosphorylation site of adducin for PKM as well as
for PKC.
In a recent study, we have demonstrated that recombi-
nant 
 
b
 
335–726
 
 adducin has comparable activity with that of
erythrocyte adducin (Li et al., 1998). Therefore, 
 
b
 
335–726
 
adducin was first used to investigate phosphorylation ef-
fects on its actin capping activity. PKM phosphorylation of
the MARCKS-related domain (1.9 mol Pi/mol 
 
b
 
335–726
 
)
greatly reduced the capping activity of 
 
b
 
335–726
 
 adducin
from 68 to 12% at 0.5 
 
m
 
M of the construct (Fig. 1 
 
B
 
). Simi-
lar results were obtained at up to 1 
 
m
 
M of the construct
(data not shown). The ability of PKM phosphorylation to
eliminate the barbed end capping activity of adducin was
also seen in actin depolymerization experiments, as evi-
denced by the return of the depolymerization rate in the
presence of adducin phosphorylated by PKM to that of pure
actin (Fig. 1 
 
C). PKM phosphorylation of the MARCKS-
related domain (0.9 mol Pi/mol subunit) also greatly re-
duced the capping activity of native adducin (Fig. 1 D).
The average reduction of capping activity by phosphoryla-
tion was 64 6 14%. Similar results were obtained using
b335–726 (data not shown).
Spectrin recruiting activity of adducin was also found to
be a target of regulation through phosphorylation of the
MARCKS-related domain. Phosphorylation of adducin by
PKM almost completely abolished spectrin recruiting ac-
tivity at up to 600 nM of the phosphorylated adducin (Fig.
2). Since adducin promotes binding of spectrin to the fast-
growing ends of actin filaments in addition to filament
sides (Li et al., 1998), recruitment of spectrin to both the
ends and sides of actin filaments is inhibited by PKM
phosphorylation. PKM phosphorylation showed a stron-
ger effect on spectrin recruitment activity than actin cap-
ping, although the basis for this difference is not known.
This is the first demonstration that actin filament capping
Figure 1. Phosphorylation by PKM of the MARCKS-related do-
main inhibits actin capping and spectrin recruitment activities of addu-
cin. (A) Erythrocyte adducin (2.5 mM monomer) was incubated with
the catalytic domain of PKC (PKM) in the presence of [32P]ATP. The
stoichiometry of phosphorylation was 0.9 mol Pi/mol subunit. The
V8 protease fragments of phosphoadducin were separated with 3.5–
17% PAGE and autoradiographed. An autoradiography of the ra-
dioactive fragments eluted from an S-Sepharose column by 0.5 M
NaBr was also shown. The arrow indicates the position where the
MARCKS-related domain of b adducin migrates. (B) PKM effect on
actin capping by b335–726. b335–726 (5 mM) was preincubated with PKM in
the presence or absence of ATP, and the reaction was quenched by add-
ing bisindolylmaleimide (50 nM). ATP was added to unphosphob335–726
after terminating the reaction. Elongation was initiated by the addi-
tion of F-actin nuclei (final 0.25 mM) and salts (final 50 mM KCl and 1 mM MgCl2) to a 4 mM G-actin solution (5% pyrenyl actin) with
or without 0.5 mM of each b335–726. The stoichiometry of phosphorylation was 1.9 mol Pi/mol b335–726. (C) Effect of PKM phosphorylation
on the ability of b335–726 to inhibit the rate of actin depolymerization. The same samples used in the polymerization assay (B) were used.
F-actin (10 mM) was diluted into G buffer containing 0.5 mM of b335–726 or phosphob335–726 to a final concentration of 0.5 mM. Data are
representative of three measurements. (D) Percentage of inhibition of elongation (percent capping) plotted against increasing concen-
trations of unphospho- (open circles) or phospho- (filled circles) adducin. The polymerization rate was calculated as a percentage of the
rate of polymerization in the absence of adducin 30–150 s after initiation and was used to calculate the capping rate. The concentrations
were expressed as monomer of adducin. Data are averages of at least three measurements. Kcap value (concentration required to pro-
duce 50% inhibition of polymerization) of unphosphorylated adducin was calculated as 125 nM monomer.Matsuoka et al. Adducin Phosphorylation in Dendritic Spines 489
and spectrin recruiting activities of adducin can be regu-
lated by phosphorylation of the MARCKS-related do-
main. The MARCKS-related domain is thus a site of regu-
lation for actin filament capping and spectrin recruiting
activities of adducin as well as the primary functional do-
main for these activities.
Phosphorylation of the MARCKS-related Domain of 
Adducin Occurs In Vivo
Antibodies specific to phosphorylated sites of a substrate
are particularly useful tools to evaluate the extent of in
vivo phosphorylation and to determine the cellular local-
ization of phosphorylated proteins (Nishizawa et al., 1991;
Dent and Meiri, 1992; Matsuoka et al., 1992; Liao et al.,
1995). We produced an antibody against a peptide, FRTP-
phosphoSFLKK, containing the phosphorylated form of
the RTPS-serine, which is the major site of phosphoryla-
tion by PKC of adducin (Matsuoka et al., 1996). The
RTPS-serine is also phosphorylated by PKA, although the
Km of PKA for adducin is 10-fold higher than that of PKC
(Matsuoka et al., 1996).
Immunoblots revealed that the RTPS-phosphoserine–
specific antibody has negligible reactivity towards adducin
in unstimulated human erythrocytes (Fig. 3 A, a), but at
least a 10-fold increase in signal occurred after activation
of PKC by addition of phorbol ester (PMA) (Fig. 3 A, c).
The phosphoadducin antibody was specific for adducin
based on lack of reaction with other proteins in crude ho-
mogenates or with recombinant human MARCKS protein
(data not shown). Moreover, the antibody reaction was
displaced completely by a 10-fold molar excess of the
phosphopeptide (data not shown). An eight- to ninefold
increase in reactivity with the phosphoadducin-specific an-
tibody occurred after PMA treatment of human embryo-
nal kidney (HEK 293) cells (Fig. 3 A, d and f), and a two-
fold increase occurred in rat hippocampal slices (Fig. 3 A,
g and i). In contrast to PMA, forskolin (50 mM), an adeny-
lyl cyclase activator, even in combination with a phos-
phodiesterase inhibitor (IBMX, 50 mM), resulted in only a
1.4-fold increase of the phosphorylation in HEK 293 cells
(Fig. 3 A, b, e, and h). Thus, the RTPS-serine in the
MARCKS-related domain of each adducin subunit is an in
vivo  phosphorylation site for PKC or other PMA-acti-
vated kinases but not PKA. A 90-kD adducin polypeptide
detected in HEK 293 cells may correspond to the human
counterpart of rat g adducin (Dong et al., 1995) (Fig. 3 A, f).
Recombinant human a adducin (residues 536–737) was
used to produce an anti–a adducin antibody. The affinity-
purified antibody specifically recognized a adducin in hu-
man erythrocytes (Fig. 3 B, a–c). The amount of a adducin
was used, as a representative of adducin subunits, to nor-
malize the amount of phosphoadducin in each sample. a
and b adducin in HEK 293 cells and rat hippocampal ly-
sates migrated at the same position as human erythrocyte
a adducin, as confirmed by antibodies specific to human a
(Fig. 3 B, d–f and g–i) and b (data not shown) adducin.
Specificity of the phosphoadducin antibody was fur-
ther analyzed using a adducin mutated at Ser716Ala/
Ser726Ala and resistant to phosphorylation by PKC (re-
ferred to as a adducinDpkc). The HA epitope–tagged a ad-
ducin and a adducinDpkc expressed in MDCK cells were
immunoprecipitated by an anti–HA epitope antibody fol-
lowed by immunoblot with the phosphoadducin-specific
antibody. Reactivity of the phosphoadducin antibody for
the HA epitope–tagged a adducin was increased about
threefold after PMA treatment (0.1 mM, 15 min) of the
cells, whereas the antibody showed no reactivity toward a
adducinDpkc (Fig. 3 C). Lack of reactivity of the phospho-
adducin antibody with a adducinDpkc provides additional
support for its specificity toward the RTPS-phosphoserine
of adducin.
The RTPS-Phosphoserine Adducin and Spectrin 
Accumulate in the Cytoplasm in MDCK Cells after 
PMA Treatment
a adducin and spectrin were concentrated at the cell mem-
brane of cell–cell contact sites in serum-starved MDCK
cells as reported previously (Fig. 4 A and Kaiser et al.,
1989). The anti–a adducin antibody also consistently
showed weak nuclear staining (Fig. 4 A, b and e). Very low
levels of the RTPS-serine phosphorylation was detected in
the cytoplasm, while none was detected at the cell–cell
contact sites of the cells using the phosphoadducin antibody
(Fig. 4 B, b). When the cells were stimulated with PMA, lev-
els of a adducin slightly but significantly increased in the cy-
toplasm (Fig. 4 A, e). Increase of the RTPS-phosphoserine
adducin was clearly observed in the cytoplasm (Fig. 4 B,
e). The increases of a adducin and the phosphoadducin
were accompanied by redistribution of spectrin from the
cell–cell contact sites into the cytoplasm (Fig. 4, A and B).
Phosphoadducin and spectrin were distributed in a punc-
tate pattern in the cytoplasm after PMA treatment (Fig. 4
B, d and e). Redistribution of adducin and spectrin from
the cell membrane into the cytoplasm has been reported in
several types of epithelial cells treated with PMA (Kaiser
et al., 1989; Dong et al., 1995). Similar results were also ob-
tained using HEK 293 cells (data not shown). Therefore,
phosphorylation of the RTPS-serine in adducin appears to
correlate closely with redistribution of the protein and
spectrin from the cell membrane into the cytoplasm. This
is consistent with the biochemical data showing that phos-
phorylation of the MARCKS-related domain by PKC
interferes with interactions of adducin with spectrin and
actin.
Figure 2. PKM effect on spec-
trin recruitment by adducin.
125I-labeled brain spectrin was
incubated with biotinylated
actin (0.4 mM) coupled onto
avidin microspheres in 60 ml
of a reaction mixture (30 mM
Hepes, pH 7.0, 50 mM KCl, 2
mM MgCl2, 1 mM NaEGTA,
10% sucrose, 0.05% Tween-
20, 2 mg/ml BSA, 0.5 mM
ATP, 0.2 mM DTT, 0.5 mM
NaN3) in the presence of increasing concentrations of unphos-
pho- (open circles) or phospho- (filled circles) adducin for 1 h at
48C. Actin-bound spectrin was separated from unbound by layer-
ing the mixture onto 200 ml of 20% sucrose barrier dissolved in
the same buffer and centrifuging for 10 min at 5,000 g. Data are
averages of at least two measurements.The Journal of Cell Biology, Volume 142, 1998 490
Phosphorylation State of the MARCKS-related Domain 
Determines Adducin Distribution in MDCK Cells
Roles of the phosphorylation state of the MARCKS-
related domain in determining distribution of adducin and
spectrin were evaluated by transfecting cells with a ad-
ducinDpkc, which was resistant to phosphorylation by PKC
at the MARCKS-related domain. MDCK cell lines were
generated that stably expressed the HA epitope–tagged
human  a adducin (MDCK/a add) and the mutant human a
adducin (MDCK/a addDpkc) (see Materials and Methods).
The HA epitope–tagged human a adducin and spectrin
in MDCK/a add cells were concentrated at the cell mem-
brane at sites of cell–cell contact (Fig. 5, a–c) as observed
for the native proteins in nontransfected cells (Fig. 4 A).
We assumed that a PKC-unphosphorylatable version of
adducin would stay at the cell membrane even after PMA
treatment if phosphorylation of the PKC sites in
MARCKS-related domain was responsible for the redis-
tribution of adducin. Surprisingly, the mutant a adducin
was not localized at the cell–cell contact sites of the PMA-
untreated cells, but instead exhibited a punctate distribu-
tion in the cytoplasm (Fig. 5, d and f). Moreover, cells ex-
pressing the mutant a adducin exhibited increased levels
of cytoplasmic spectrin in a punctate pattern, which was in
some cases colocalized with the mutant a adducin (Fig. 5, e
and f). This result clearly showed involvement of the PKC
phosphorylation sites in controlling subcellular distribu-
tion of adducin as well as spectrin. The nature of the punc-
tate structures containing the mutant adducin and spectrin
Figure 3. Specificity of the an-
tiphosphoadducin and anti–a ad-
ducin antibodies and effect of
forskolin and PMA on adducin
phosphorylation in vivo. Western
blot analysis for the antiphos-
phoadducin antibody (3.5 mg/
ml) (A) and the anti–a adducin
antibody (1 mg/ml) (B). Lanes
a–c, human erythrocyte mem-
brane; lanes d–f, human embry-
onal kidney (HEK 293) cells;
lanes  g–i, rat hippocampal slices.
Lanes  a,  d, and g, unstimulated
conditions; lanes b, e, and h, 50
mM forskolin/50 mM IBMX treat-
ment; lanes c, f, and i, 1 mM PMA
treatment. Both a and b adducin
in HEK 293 cells and rat hippo-
campal lysates migrated at the
same position of human erythro-
cyte a adducin (lanes d–f and g–i).
Each lane was loaded with 10 mg
total protein. (C) Confluent cul-
tures of stable MDCK cells ex-
pressing HA epitope–tagged full-
length human a adducin and the
PKC sites mutant were serum
starved overnight and were ei-
ther untreated or treated with
0.1 mM PMA for 15 min. After
washing with ice-cold PBS con-
taining 2 mM PMSF, the cells
were lysed with an ice-cold lysis
buffer (1 ml/ø10-cm dish) con-
sisting of 20 mM Tris-HCl, pH
7.5, 100 mM NaCl, 2 mM sodium
EGTA, 2 mM sodium EDTA,
50 mM NaF, 100 nM caliculin A,
1% Triton X-100, 1% NP-40, 10
mg/ml leupeptin, 10 mg/ml pep-
statin A, 1 mM bebzamidine, and
1 mM PMSF using a glass-Teflon
pestle homogenizer. The lysate was cleared by centrifugation at 15,600 g for 10 min. The HA epitope–tagged a adducin was immunopre-
cipitated for 3 h at 48C from 1 ml of cell lysate using an HA-specific mouse IgG preadsorbed on protein G–Sepharose beads (50 ml;
Pharmacia Biotech). The beads were washed twice with lysis buffer and then twice with the same buffer without Triton and NP-40 be-
fore addition of 100 ml SDS-sample buffer. Erythrocyte adducin phosphorylated by PKM was used as a positive control for the RTPS-
serine phosphorylation.Matsuoka et al. Adducin Phosphorylation in Dendritic Spines 491
has not been resolved, but they could represent vesicles en
route to or returning from the plasma membrane.
Localization of the RTPS-Phosphoserine Adducin in 
the Hippocampus
High levels of the phosphoadducin were detected in the
dendritic fields, i.e., stratum radiatum and stratum oriens,
of CA1 region in P15 rat hippocampus (Fig. 6 a). In the
dentate gyrus, the staining intensity for phosphoadducin
was higher in the hilus region than in the molecular layer
(Fig. 6 a). In the dendritic fields of CA3 region, phospho-
adducin staining was slightly weaker than CA1 region
(Fig. 6 b). Confocal microscopy for stratum radiatum of
CA1 region at high magnification revealed phosphoadducin
antibody staining of round and elliptical structures with di-
ameters ,1 mm (Fig. 6 c). Double labeling with antibodies
against synaptophysin and the phosphoadducin revealed
that some of the phosphoadducin-stained structures were
immediately adjacent to presynaptic endings defined by
synaptophysin staining. (Fig. 6 c, arrows). Synaptophysin is
a marker for neurosecretory vesicles, which are concen-
trated at presynaptic endings (Wiedenmann and Franke,
1985). Therefore, at least a subpopulation of the phospho-
adducin-positive structures may correspond to dendritic
spines, which are specialized postsynaptic structures.
Figure 4. Redistributions of the RTPS-
phosphoserine adducin and spectrin af-
ter PMA treatment in MDCK cells.
Confluent cultures of MDCK cells
were treated without (a–c) or with
(d–f) 0.1 mM PMA for 30 min fol-
lowed by double staining with spec-
trin bG- (a and d) and a adducin- (b
and e) specific antibodies (A) or with
spectrin bG- (a and d) and phospho-
adducin- (b and e) specific antibodies
(B). Composite images show colocal-
ization of signals (yellow; c and f). Pri-
mary antibodies were used at the indi-
cated concentrations: anti–spectrin
bG (5 mg/ml), anti–a adducin (3 mg/ml),
and antiphosphoadducin (3.5 mg/ml)
antibodies. All images were taken at
the nucleus level. Fluorescent images
were visualized by a confocal laser mi-
croscope (model LSM 410; Carl Zeiss,
Inc., Thornwood, NY). Bars, 10 mm.The Journal of Cell Biology, Volume 142, 1998 492
Localization of the Phosphoadducin in Dendritic Spines 
of Cultured Hippocampal Neurons
Resolution of dendritic spines is difficult in brain tissue sec-
tions, but these structures can be visualized in cultured hippo-
campal neurons. Distributions of the RTPS-phosphoserine
adducin and total adducin were compared in cultured hippo-
campal neurons using the phosphoadducin-specific and the
MARCKS-related domain–specific antibodies, respec-
tively. Phosphoadducin was highly concentrated in spots
flanking dendrites, which we interpret to be dendritic spines
based on colocalization with AMPA receptors (a non-
NMDA glutamate receptor) detected using antibody
against the GluR2/4 subunits (Fig. 7, a–c, arrowheads). At
least 80% of the spots contained both proteins, although in
some cases the phosphoadducin-positive spots did not con-
tain GluR2/4 and vice versa (Fig. 7, compare a and b). This
result strongly supports the interpretation that the small
structures containing high levels of the phosphoadducin
observed in brain sections (Fig. 6 c) are dendritic spines.
Neither glutamate nor PMA treatment caused further
increase in the level of adducin phosphorylation in spines
(the ratio of the signals, phosphoadducin/glutamate recep-
tor, was used to assess changes of adducin phosphoryla-
tion, n 5 20 each) (Fig. 7, d–i). The cultures were preincu-
bated with glutamate-free medium in the presence of high
Mg21 (15 mM) and an AMPA receptor antagonist (CNQX)
to block NMDA and non-NMDA receptors, respectively
(see Materials and Methods). Adducin therefore already
was fully phosphorylated in the dendritic spines of hippo-
campal neurons under resting conditions in culture. However,
PMA treatment did strongly enhance levels of the phospho-
adducin located at the plasma membrane of cell body, the
cytoplasm and dendrites (Fig. 7 h). The membrane-associ-
ated phosphoadducin was unanticipated. This result suggests
involvement of additional domains, such as the head do-
main, for adducin to associate with the cell membrane.
Total adducin staining using antibody against the
MARCKS-related domain, in contrast to the phosphoad-
ducin, was observed along the entire cell membrane and in
the cytoplasm of cell body and dendrites as well as in the
dendritic spines (Fig. 8, a–c). No significant changes of ad-
ducin distribution were observed after glutamate and
PMA treatments of the neurons (Fig. 8, d–f and g–i). How-
ever, the MARCKS-related domain–specific antibody has
weak reactivity with the RTPS-phosphoserine adducin
and underrepresents phosphoadducin (data not shown).
These results combined with Fig. 7 demonstrate that addu-
cin is uniformly distributed along the plasma membrane
and that dendritic spines are the most active sites for addu-
cin phosphorylation in hippocampal neurons.
Spectrin bG was located mostly in a punctate pattern as-
sociated with dendrites that were not labeled with the
phosphoadducin antibody (Fig. 9). These findings suggest
that spectrin and phosphoadducin exist in distinct sites in
neurons.
Discussion
This study presents the first evidence that phosphorylation
of the RTPS-serine in the MARCKS-related domain of ad-
ducin occurs in vivo and has an important role in regulating
distribution of adducin in cells. Furthermore, phosphoryla-
tion by PKC of adducin at the MARCKS-related domain
inhibits adducin activities of promoting spectrin–actin inter-
actions and capping the fast-growing ends of actin filaments.
PMA-activated phosphorylation of the RTPS-serine was
demonstrated, using a phosphoadducin-specific antibody,
in erythrocytes, HEK 293 cells (human embryonic kidney
origin), brain slices, and MDCK cells. A PKC-unphosphor-
ylatable S716A/S726A mutant a adducin expressed in
MDCK cells was distributed in a cytoplasmic punctate pat-
tern and was no longer concentrated at the cell membrane
Figure 5. Effects of the mutation at
PKC phosphorylation sites of a adducin
on distributions of a adducin and spec-
trin in MDCK cells. Distributions of HA
epitope–tagged  a adducin and spec-
trin were detected by anti-HA epitope
(1:1,000) and antispectrin (1.5 mg/ml)
antibodies, respectively. (a–c) MDCK/a
add cells. (d–f) MDCK/a addDpkc cells.
(c and f) Higher-magnification compos-
ite images of the boxed areas. Note that
a adducinDpkc showed a diffuse punctate
staining pattern in the cytoplasm of
MDCK/a addDpkc cells. Arrows indicate
structures where a adducinDpkc and spec-
trin colocalize. All images were taken at
the nucleus level. Bar: (a, b, d, and e)
10 mm; (c and f) 1 mm.Matsuoka et al. Adducin Phosphorylation in Dendritic Spines 493
at sites of cell–cell contact. Moreover, cells expressing the
mutant a adducin exhibited increased levels of cytoplas-
mic spectrin, which was colocalized with the mutant addu-
cin in a punctate pattern. Finally, high levels of the RTPS-
serine phosphorylation were visualized in sections of rat
hippocampus and in the dendritic spines of cultured hip-
pocampal neurons.
Dendritic spines are dynamic structures that receive the
majority of exitatory synaptic connections in the mamma-
lian central nervous system (Harris et al., 1992; Papa et al.,
1995; Ziv and Smith, 1996). Dendritic spines change in
shape during neuronal development as well as concurrently
with long-term potentiation, a widely studied experimental
model of learning (Fifkova and Van Harreveld, 1977;
Schuster et al., 1990; Geinisman et al., 1991; Hosokawa et al.,
1995). Actin and actin-binding proteins, including spectrin,
adducin, and myosin, are the major cytoskeletal components
in dendritic spines, where microtubules and neurofilaments
are virtually absent (Westrum et al., 1980; Landis and Reese,
1983; Morales and Fifkova, 1989; Seidel et al., 1995). The
actin filaments of the spine neck are longitudinally situ-
ated, whereas those in the head are organized into a lattice
(Fifkova and Delay, 1982). This organization suggests that
actin filaments provide the basic structural scaffolding of
the spine (Harris and Kater, 1994). Thus, changes in the
spine actin network through modulation of the activities of
actin-regulating proteins have been proposed as a basis for
activity-dependent structural changes in spine morphology
(Coss and Perkel, 1985; Fifkova and Morales, 1991).
Synaptic stimulation of dendritic spines induces an increase
in Ca21 up to micromolar levels (Holmes, 1990; Gold and
Bear, 1994). Probable targets for Ca21 in dendritic spines
include calmodulin (Malenka et al., 1989; Ehlers et al., 1996;
Wyszynski et al., 1997), PKC (Malinow et al., 1989; Abelio-
vich et al., 1993; Hrabetova and Sacktor, 1996), Ca21/calmod-
ulin-dependent protein kinase II (CaMKII) (Silva et al., 1992;
Kennedy, 1993; Lledo et al., 1995), and Ca21/calmodulin-
dependent protein phosphatase 2B or calcineurin (Mulkey et
al., 1994). Among substrates for these enzymes are several
cytoskeletal proteins, including microtubule-associated pro-
tein 2, (Quinlan and Halpain, 1996), myosin (Kawamoto et
al., 1989), and adducin. However, adducin is the first cyto-
skeletal protein directly demonstrated to be phosphorylated
in dendritic spines of living hippocampal neurons. Given the
biochemical activities of adducin in promoting assembly of
spectrin–actin complexes and that these activities of adducin
are regulated by PKC and calmodulin, adducin is a logical
candidate to participate in activity-dependent shape changes
of dendritic spines. In addition, the striking localization of
phosphoadducin in the spines further supports the idea that
dendritic spines are distinct biochemical and Ca21 compart-
ments (Guthrie et al., 1991; Müller and Connor, 1991; Koch
and Zador, 1993; Yuste and Denk, 1995).
The identity of adducin kinase(s) and phosphatases re-
sponsible for regulating the phosphorylation state of addu-
cin in dendritic spines remains to be determined. Since
CaMKII does not phosphorylate a or b adducin in vitro
(Matsuoka, Y., unpublished results) and PKA does not in
vivo (Fig. 1 A), an isoform of PKC is the most likely candi-
date. It is noteworthy that at least one isoform of PKC,
PKCg, is localized in dendritic spines by immunoelectron
microscopy (Tsujino et al., 1990; Saito et al., 1994). Phos-
phoadducin is likely to be a substrate for protein phos-
phatase(s) in dendritic spines, which could represent an
important aspect of activity-dependent regulation of addu-
cin functions. Calcineurin, a Ca21/calmodulin-dependent
protein phosphatase, is present at high levels in hippocam-
pal neurons (Steiner et al., 1992) and is a good candidate
for an adducin phosphatase.
Kaibuchi and colleagues have found that adducin is an
in vivo substrate for Rho-associated kinase (Rho-kinase)
and myosin phosphatase, which are involved in the regula-
tion of actin cytoskeleton in the cells (Amano et al., 1997;
Kimura et al., 1998). Phosphorylation by Rho-kinase oc-
curs at a different site from PKC and increases the affinity
of a adducin for F-actin (Kimura et al., 1998). It will be of
interest to determine localization of Rho-kinase–phosphor-
ylated adducin in neurons and possibly dendritic spines.
The basic MARCKS-related domain of adducin has re-
cently been demonstrated to be required for association of
adducin with spectrin and actin (Li et al., 1998). Moreover,
activity of adducin in promoting association of spectrin
with actin is inhibited by high ionic strength, consistent
with an electrostatic origin of binding energy between ad-
ducin and actin (data not shown). These findings consid-
ered together with the evidence in this study that phosphor-
ylation of a site in the MARCKS-related domain inhibits
Figure 6. Distribution of the RTPS-phosphoserine adducin in rat
hippocampus. (a and b) Low-magnification confocal images of
P15 rat hippocampus stained with the phosphoadducin-specific
antibody. The boxed area was examined with higher magnifica-
tion. (c) High-magnification image of CA1 region. A composite
confocal image for the phosphoadducin (green) and synapto-
physin (red) was shown. Arrows indicate putative dendritic
spines stained with the phosphoadducin antibody. Bars: (a and b)
250 mm; (c) 2.5 mm.The Journal of Cell Biology, Volume 142, 1998 494
actin interactions suggest that this domain provides a di-
rect contact with actin. Incorporation of phosphate with its
bulk and negative charge into the basic MARCKS-related
domain would be anticipated to interfere with electrostatic
interactions dependent on positively charged residues.
These considerations suggest that the actin contact sites
for adducin will include negatively charged residues. Neg-
atively charged residues (aspartate or glutamate) are ex-
posed on the lateral surface of rabbit skeletal actin in posi-
tions 1–4, 24, 25, 99, 100, 360, 361, 363, and 364, while
residues 167, 288, and 292 are located at the fast-growing
ends of actin filaments (Holmes et al., 1990; Kabsch et al.,
1990). The negatively charged residues exposed on the lat-
eral surface of actin have been implicated in association
with a positively charged lysine-rich loop in the head do-
main of myosin (Rayment et al., 1993; Schröder et al., 1993)
and make up a possible actin–myosin interface (Holmes et
al., 1990; Kabsch et al., 1990; Johara et al., 1993). It will be
of interest to determine if adducin can inhibit actin-acti-
vated Mg21-ATPase activity of myosin and if such effects
are controlled by phosphorylation of adducin.
Nonphosphorylatable mutant adducin (a adducinDpkc)
and spectrin were colocalized as a punctate pattern in the
cytoplasm of MDCK/a addDpkc cells (Fig. 5 f). The identity
of structures containing the mutant adducin and spectrin is
not known but could represent vesicles in transit between
the Golgi and plasma membrane. It is interesting in this re-
gard that adducin and spectrin associate with dynactin,
which is a multiprotein complex including an actin-related
protein Arp1 or centractin and promotes dynein-mediated
vesicle motility along microtubules (Schafer et al., 1994;
Holleran et al., 1996). It will be of interest to determine if
the structures with the mutant adducin contain other
members of the dynactin complex.
We propose adducin as a candidate for a Ca21/calmodu-
lin- and phosphorylation-sensitive modulator of the orga-
nization of spectrin–actin complexes in a variety of dy-
namic cellular domains. PKC has been demonstrated to be
involved in reorganization of the actin cytoskeletons cou-
pling with membrane ruffling in neutrophils (Downey et al.,
1992), spreading of platelets (Haimovich et al., 1996), and
integrin clustering in lymphocytes (Pardi et al., 1992). Addu-
cin, based on results of this study, is a candidate downstream
effector of PKC in these cells and possibly in dendritic
spines. Since homologues of mammalian adducin have been
identified in Caenorhabditis elegans (Moorthy, S., L. Chen,
and V. Bennett. 1997. Mol. Biol. Cell. 8:274a), adducin may
have a fundamental role conserved during evolution in
regulation of assembly of spectrin–actin complexes in neu-
rons as well as other types of cells.
Figure 7. Colocalization of phosphoad-
ducin with GluR2/4 and specific phos-
phorylation of adducin in dendritic
spines of cultured hippocampal neurons.
Colocalization of GluR2/4 (green; a, d,
and g) and phosphoadducin (red; b, e,
and h). (a–c) Neurons before stimula-
tion; (d–f) after glutamate (10 mM)
stimulation; (g–i) after PMA (1 mM)
stimulation. Composite images show
colocalization of signals (yellow; c, f,
and  i). Arrowheads represent dendritic
spines containing both phosphoaddu-
cin and AMPA-receptor (a–c). Neither
glutamate nor PMA treatment caused
further increase in the level of adducin
phosphorylation in spines (ratio of the
signals, phosphoadducin/glutamate re-
ceptor, was used to assess changes of
adducin phosphorylation, n 5 20 each)
(d–i). Primary antibodies were used at
the indicated concentrations: antiphos-
phoadducin (3.5 mg/ml) and monoclonal
anti–GluR2/4 3A11 (5 mg/ml) antibod-
ies. Fluorescent images of hippocampal
neurons were visualized by a confocal
laser microscope (model LSM 410; Carl
Zeiss, Inc.). Bar, 10 mm.Matsuoka et al. Adducin Phosphorylation in Dendritic Spines 495
Figure 8. Colocalization of adducin with
GluR2/4 in cultured hippocampal neu-
rons. Colocalization of GluR2/4 (green;
a, d, and g) and whole adducin (red; b, e,
and  h). (a–c) Neurons before stimula-
tion; (d–f) after glutamate (10 mM)
stimulation; (g–i) after PMA (1 mM)
stimulation. Composite images show
colocalization of signals (yellow; c, f, and
i). Note that the cell membrane staining
of cell body becomes weaker after PMA
treatment because the anti–MARCKS-
related domain antibody has much less
reactivity toward the phosphoadducin
than unphosphoadducin. Primary anti-
bodies were used as at the indicated
concentrations: anti–MARCKS-related
domain (1.6 mg/ml) and monoclonal
anti–GluR2/4 3A11 (5 mg/ml) antibod-
ies. Fluorescent images of hippocampal
neurons were visualized by a confocal
laser microscope (model LSM 410; Carl
Zeiss, Inc.). Bar, 10 mm.
Figure 9. Localization of spectrin bG and
the phosphoadducin in cultured hippo-
campal neurons. Localization of spectrin
bG (green; a and d) and the RTPS-phos-
phoserine adducin (red; b and e) in den-
drites. Composite images show colocaliza-
tion of signals (yellow; c and f). The
neurons were treated without (a–c) or with
(d–f) PMA. Primary antibodies were
used at the indicated concentrations:
anti–spectrin  bG (5 mg/ml) and antiphos-
phoadducin (3.5 mg/ml) antibodies. Flu-
orescent images of hippocampal neurons
were visualized by a confocal laser mi-
croscope (model LSM 410; Carl Zeiss,
Inc.). Bar, 5 mm.The Journal of Cell Biology, Volume 142, 1998 496
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